DaylightGov

H.R. 8358 · 119th Congress · Referred to the Committee on Oversight and Government Reform, and in addition to the Committees on Energy and Commerce, and Armed Services, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

Breast Cancer Research Stamp Reauthorization Act of 2026

We have not deep-analyzed this bill yet.

Here is what Congress.gov shows.

Sponsor
Rep. Van Duyne, Beth [R-TX-24] (R-TX), House
Cosponsors
10 cosponsors
  • Rep. Bacon, Don [R-NE-2] (R-NE)
  • Rep. Cohen, Steve [D-TN-9] (D-TN)
  • Rep. Craig, Angie [D-MN-2] (D-MN)
  • Rep. Dingell, Debbie [D-MI-6] (D-MI)
  • Rep. Fitzpatrick, Brian K. [R-PA-1] (R-PA)
  • Rep. Garamendi, John [D-CA-8] (D-CA)
  • Rep. LaLota, Nick [R-NY-1] (R-NY)
  • Rep. Mackenzie, Ryan [R-PA-7] (R-PA)
  • Rep. Matsui, Doris O. [D-CA-7] (D-CA)
  • Rep. Wasserman Schultz, Debbie [D-FL-25] (D-FL)
Introduced
April 16, 2026
Latest action
Referred to the Committee on Oversight and Government Reform, and in addition to the Committees on Energy and Commerce, and Armed Services, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. (April 16, 2026)
Scanned
July 23, 2026
Read the bill text on Congress.gov

Public record

Below is the official voting record from Congress.gov. It is not our analysis.

Source: Congress.gov

This bill has no recorded roll-call vote yet. A roll-call vote records how each member voted by name.